Company intelligence / Profile preview

UGA Biopharma

Hennigsdorf, Brandenburg, Germanyugabiopharma.com ↗

Ownership: Private
Employees: ~21
Development stage: Commercial

Overview

UGA Biopharma specializes in the rapid, cost-effective development of high-quality monoclonal cell lines for biologics and biosimilars. Their proprietary technology platform enables delivery of robust CHO cell lines with high titers within four months. Products developed using their services have been used successfully in clinical studies and received market approvals, including biosimilars to adalimumab, bevacizumab, and trastuzumab.

Modalities: Monoclonal antibodyBispecific monoclonal antibodyChimeric antibodyHumanized single-chain antibody fragmentFusion proteinEnzyme replacement therapy (Enzyme)HormoneRecombinant protein
Industry: Contract Manufacturing Organization

Partnerships

Confidential; most customers remain undisclosed due to confidentiality agreements. Some non-confidential references available on request or via website.

Beyond the preview

Go deeper on UGA Biopharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on UGA Biopharma.

Explore the full profile